News: Fibrocell Equity Offering $FCSC
Fibrocell Science, Inc., an autologous cell and gene therapy company, has announced the pricing of its Equity Offering. The firm has announced the pricing of an underwritten public offering of 2.6 million shares of its common stock at a price of $5.80 per share. Gross proceeds will be approximately $13.6 million, after deducting underwriting discounts and commissions […]
News: Fibrocell Equity Offering $FCSC Read More »